Literature DB >> 7103628

Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease.

I Grant, R K Heaton, A J McSweeny, K M Adams, R M Timms.   

Abstract

As part of a six-center clinical trial of the effectiveness of continuous v nocturnal oxygen in the management of hypoxemic chronic obstructive pulmonary disease (COPD), we performed detailed neuropsychologic assessments of these patients prior to their beginning treatment. The 203 patients (age, 65 years; Pao2, 51 mm Hg; forced expiratory volume in 1 s, 0.74 L) performed significantly worse than controls on virtually all neuropsychologic tests. Moderate to severe test impairment suggestive of cerebral dysfunction was found in 42% of the patients, as compared with 14% of controls. Higher cognitive functions (abstracting ability, complex perceptual-motor integration) were most severely affected, although half the patients also showed decrements in motor speed, strength, and coordination. Low-order significant inverse correlations were found between neuropsychologic impairment and Pao2, resting arterial oxygen saturation and hemoglobin levels and maximum work. It is concluded that cerebral disturbance is common in hypoxemic COPD and may be related in part to decreased availability of oxygen to the brain.

Entities:  

Mesh:

Year:  1982        PMID: 7103628

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  80 in total

1.  A Model for Studying Neuropsychological Effects of Sleep Intervention: The Effect of 3-week Continuous Positive Airway Pressure Treatment.

Authors:  In-Soo Lee; Wayne A Bardwell; Rujvi Kamat; Lianne Tomfohr; Robert K Heaton; Sonia Ancoli-Israel; Jose S Loredo; Joel E Dimsdale
Journal:  Drug Discov Today Dis Models       Date:  2011

2.  Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation.

Authors:  W David Crews; Angela L Jefferson; Donna K Broshek; Robert D Rhodes; John Williamson; Amy M Brazil; Jeffrey T Barth; Mark K Robbins
Journal:  Arch Clin Neuropsychol       Date:  2003-05       Impact factor: 2.813

3.  Cognitive decline after hospitalization in a community population of older persons.

Authors:  R S Wilson; L E Hebert; P A Scherr; X Dong; S E Leurgens; D A Evans
Journal:  Neurology       Date:  2012-03-21       Impact factor: 9.910

4.  Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia.

Authors:  A A Okubadejo; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1996-01       Impact factor: 9.139

5.  Association of lung function with physical, mental and cognitive function in early old age.

Authors:  Archana Singh-Manoux; Aline Dugravot; Francine Kauffmann; Alexis Elbaz; Joel Ankri; Hermann Nabi; Mika Kivimaki; Séverine Sabia
Journal:  Age (Dordr)       Date:  2010-09-29

6.  Rate of Cognitive Decline Before and After the Onset of Functional Limitations in Older Persons.

Authors:  Kumar B Rajan; Liesi E Hebert; Paul A Scherr; Carlos F Mendes de Leon; Denis A Evans
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-05-02       Impact factor: 6.053

7.  Assessment of Cognitive Impairment in Patients with Chronic Obstructive Pulmonary Disease Using the Rapid Cognitive Screen.

Authors:  E Charbek; K Huynh; E Kim; R P Nayak
Journal:  J Nutr Health Aging       Date:  2019       Impact factor: 4.075

Review 8.  Cognitive and psychological issues in emphysema.

Authors:  Elizabeth Kozora; Charles Emery; Robert M Kaplan; Fredrick S Wamboldt; Lening Zhang; Barry J Make
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

9.  Breathe Easy, Speak Easy: Pulmonary Function and Language Performance in Aging.

Authors:  Dalia Cahana-Amitay; Lewina O Lee; Avron Spiro; Martin L Albert
Journal:  Exp Aging Res       Date:  2018 Oct-Dec       Impact factor: 1.645

10.  Executive Function, Survival, and Hospitalization in Chronic Obstructive Pulmonary Disease. A Longitudinal Analysis of the National Emphysema Treatment Trial (NETT).

Authors:  James W Dodd; Paul Novotny; Frank C Sciurba; Roberto P Benzo
Journal:  Ann Am Thorac Soc       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.